With six new independent studies published, 2016 turned out to be the biggest year of research so far for the natural health supplement, Modified Citrus Pectin. And with more studies on the way — including clinical trials at renowned institutes — the momentum continues to grow. Medical researchers world-wide are increasingly interested in the unique actions of this ingredient from citrus peels.
It’s unusual for a natural compound to receive this level of investigation from the scientific community. But MCP isn’t your average supplement.
In fact, as research continues, the growing body of data demonstrates that MCP is one of the MOST important strategies for maintaining long-term wellness and healthy aging. Why? Because of its singular ability to bind the rogue protein and aging biomarker, Galectin-3 (Gal-3).
Easy Health Options readers have heard me discuss Gal-3 before. That’s because the research into this field is nothing short of groundbreaking, with a fast-growing body of clinical and large-scale population studies demonstrating the driving role of elevated Gal-3 in deadly diseases including heart disease, kidney and liver failure, metastatic cancer and much more.
When Gal-3 levels in the body are too high, this pro-aging protein wreaks havoc by binding to cells and hijacking communication, allowing cancer cells to aggregate and spread, fueling chronic inflammation and fibrosis of organs and tissues, suppressing immunity, accelerating the aging process, and more. A simple Gal-3 blood test is available and covered by most insurance for cardiovascular screening, with integrative practitioners also using it to measure other areas of health such as cancer progression, and even how well their patients are aging.
Within this fast growing field of Gal-3 research, there is one solution that’s being shown time and again to halt, prevent and even reverse the degenerative effects of elevated Gal-3: Modified Citrus Pectin. In fact, MCP is becoming known as the only available Gal-3 blocker, capable of undoing the widespread damage caused by elevated Gal-3 and as a result, protecting our most critical areas of health.
Groundbreaking MCP research
The number of new studies demonstrating MCP’s broad-spectrum benefits grows each year. Here’s a snapshot of the research that came out in 2016 alone:
February 2016– A study in Plos One showed that MCP blocked Galectin-3 in an animal model of spinal injury, reducing pain and temperature sensitivity as well as reducing other markers of inflammation.
March 2016 – A study in Hypertension showed that MCP blocked Galectin-3 in the left ventricle of the heart and suppressed genes related to fibrogenesis, preventing cardiac fibrosis and damage.
May 2016 – A study in the Canadian Journal of Physiology and Pharmacology showed that MCP decreased fibrosis and inflammation in a model of liver damage, by blocking Galectin-3, inducing apoptosis and supporting antioxidant activity.
June 2016 – A study published in the International Journal of Obesity showed that MCP blocked Galectin-3 to prevent inflammation and fat tissue remodeling in a model of obesity, with important implications in metabolic diseases.
Nov 2016 – A study published in the Journal of the American Heart Association showed MCP blocked Galectin-3 to prevent valve calcification in a model of atherosclerosis, and decreased inflammation and fibrosis in aortic valves.
Nov 2016 – A study published in PLos One showed that MCP blocked Galectin-3 in two kidney tissue damage models, reducing fibrosis and demonstrating critical support for healthy kidney function. Martinez-Martinez E, et al.
Preventing chronic illness and optimizing healthy aging
Over the past 25 years, numerous clinical and preclinical studies have demonstrated the benefits of MCP including cellular, detoxification and immune health actions. Now, MCP is gaining international recognition as the only solution available to halt and reverse the effects of elevated Gal-3, making it a critical daily supplement for maintaining and optimizing long-term health, preventing and reversing some of the most difficult-to-treat diseases. Important note: MCP has to be the correct molecular weight and structure to be effective, between 3-15 kilodaltons, as shown in the published literature. This extra small size allows the MCP to absorb into the circulation and perform its critical benefits throughout the body.
As the research continues, more integrative physicians and health conscious consumers are making MCP a central part of their daily health protocols.
For more information on MCP, I recommend the book, “New Twist on Health: Modified Citrus Pectin for Cancer, Heart Disease and More” by Karolyn Gazella.
Stay tuned as research in the field of Gal-3 continues.
For more health and wellness information, visit www.dreliaz.org.